Lantus®

Sanofi’s investigational therapy Toujeo® consistently showed significantly fewer low blood sugar events compared with Lantus®

Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases in risk of low blood sugar events…

10 years ago

Sanofi filed patent infringement suit against Eli Lilly over Lantus® and Lantus® SoloStar®

Paris, France, 31-1-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it filed a patent infringement suit against Eli…

10 years ago